DAIC

NOVEMBER 8, 2024

Centers for Medicare & Medicaid Services (CMS) have granted the company’s Paradise Ultrasound Renal Denervation system a Transitional Pass-through (TPT) payment. The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries.

CMS 40

CMS Ultrasound Blood Pressure Reimbursement 40

Circulation: Cardiovascular Imaging

MARCH 13, 2025

The use of fractional flow reserve by CT per 100 000 Medicare enrollees increased by >16-fold from 2018 (the first year covered) to 2022, and cardiac amyloidosis pyrophosphate scintigraphy studies increased 4-fold from 2011 to 2022 (0.17% to 0.68%). of cardiac testing use in 2011 and 67.7% to 1.7%), stress echocardiography (3.6%

Medicare 40

Medicare Exercise Cardiovascular Imaging Technology 40

DAIC

JULY 18, 2024

CPT codes are widely used by government payers, including Medicare and Medicaid, and commercial insurance companies to identify healthcare services and procedures for reimbursement. In accordance with the AMA semi-annual early release schedule, the new codes will be effective January 1st, 2025 and published in the 2025 CPT Code book.

Reimbursement 105

Reimbursement Technology Electrocardiogram Medicaid 105

DAIC

JULY 18, 2024

The technology was introduced at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Washington, D.C. Having access to a patient’s whole coronary picture, with both quantified plaque and physiology, is a game changer as a clinician. F.A.C.C. “The For more information: www.heartflow.com References: 1.

Coronary Artery Disease 111

Coronary Artery Disease Plaque Technology Medicare 111

DAIC

MARCH 20, 2024

1 To qualify for a Breakthrough Device Designation, a device technology must address an unmet need and show that it has the potential to provide for more effective treatment of life-threatening diseases or irreversibly debilitating conditions. CLTI is associated with high rates of amputation and mortality as well as high care costs.1

Peripheral Arterial Disease 105

Peripheral Arterial Disease Innovation Technology Coronary Artery Disease 105

DAIC

JUNE 18, 2024

The designation recognizes the novelty of the technology and the potential to provide a more effective treatment option for patients with coronary artery disease. 3 “We very much appreciate FDA’s breakthrough designation recognition of the bioadaptor technology,” continued Sirhan. Food and Drug Administration (FDA). of the U.S.

Coronary Artery Disease 105

Coronary Artery Disease Technology Stents Stent 105

DAIC

MARCH 13, 2024

CMS has reviewed the CardiAMP Heart Failure II Trial and approved the investigational product, related and routine items and services for purposes of Medicare coverage. Getty Images milla1cf Wed, 03/13/2024 - 16:49 March 13, 2024 — BioCardia, Inc. ,

CMS 111

CMS Heart Failure Reimbursement Quality of Life 111

DAIC

MARCH 7, 2024

Computed Tomography (CT) continues to be a rapidly evolving technology with many new advancements, as displayed and discussed at the Radiological Society of North America109th Scientific Assembly and Annual Meeting (RSNA23). As a whole, the computed tomography market size in the US in 2024 is estimated to be $2.38 Halpern, MD, and Vijay M.

Technology 111

Technology Document Cardiovascular Imaging Cancer 111

Society of Thoracic Surgeons - Technology

OCTOBER 21, 2021

The linkage also would allow registries to continue providing critical information for approval and coverage of innovative medical interventions and preserve the government’s authority to authorize Medicare Coverage with Evidence Development (CED). Download the PDF version Advocacy Quality Improvement Technology

Technology 40

Technology Coronary Artery Bypass Graft Cardiothoracic Aortic valve 40

American College of Cardiology

JULY 10, 2024

The Office of the National Coordinator for Health Information Technology (ONC) released on July 10 the Health Data, Technology, and Interoperability: Patient Engagement, Information Sharing, and Public Health Interoperability (HTI-2) proposed rule, building on the HTI-1 final rule released in 2023 and additional information blocking rules released (..)

CMS 42

CMS Medicaid Public Health Medicare 42

DAIC

JUNE 12, 2024

Consequently, Philips is well positioned to support CVI treatment by offering a robust portfolio of medical technology that includes both intravascular ultrasound and a differentiated venous stenting system.” Utilization of and Outcomes Associated with Intravascular Ultrasound during Deep Venous Stent Placement among Medicare Beneficiaries.

Stents 105

Stents Stent Anatomy Ultrasound 105

DAIC

MAY 8, 2024

2-4 HeartFlow’s non-invasive FFR CT technology has emerged as a leading frontline strategy for accurately diagnosing hemodynamically significant coronary lesions in patients suspected of having CAD. Longitudinal assessment of safety of FEMOROPOPLITEAL endovascular treatment with paclitaxel-coated devices among Medicare beneficiaries.”

Coronary Artery Disease 111

Coronary Artery Disease Chest Pain Myocardial Infarction Ischemia 111

GEMMS

APRIL 8, 2024

Established by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) , the MIPS Program is pivotal in determining Medicare payment adjustments for healthcare practices. What is MIPS?

Medicare 52

Medicare Innovation Medicaid Patient Care 52

CardiacWire

APRIL 10, 2024

GLP-1s Are So Hot Right Now – In the year since ACC 2023, GLP-1s went from a weight loss and diabetes drug that “might” have cardiovascular benefits to becoming a promising (and Medicare-covered) option for CV event reduction.

Innovation 59

Innovation Technology Interventional Cardiology Medicare 59

DAIC

JUNE 4, 2024

In January 2024, the Centers for Medicare and Medicaid Services (CMS) began requiring health care organizations to screen for five social factors: Food insecurity Interpersonal safety Housing insecurity Transportation Utilities The purpose of these screenings is to encourage engagement of community-based organizations with resources to address SDOH.

Strokes 115

Strokes Stroke Innovation Research 115

DAIC

MARCH 7, 2024

The data was presented today by Amish Raval , MD, Director of Clinical Cardiovascular Research and Professor of Medicine at the University of Wisconsin-Madison at the Technology and Heart Failure Therapeutics (THT) 2024 annual meeting. The CardiAMP HF II trial is expected to similarly secure CMS reimbursement.

Heart Failure 105

Heart Failure Biomarkers Reimbursement CMS 105

Wellnest

JUNE 19, 2023

The development has urged us to integrate the latest Artificial Intelligence with the healthcare system, including Cardiac Medicare. By harnessing the power of the latest technology, healthcare providers can enhance diagnostics, treatment planning, and patient care. What is Artificial Intelligence?

Technology 52

Technology Cardiac Arrest Innovation Coronary Artery Disease 52

DAIC

JANUARY 3, 2024

3 HeartFlow’s FFR CT Analysis is covered by Medicare and for >99% of commercially insured lives. With more than 500 peer-reviewed publications, the HeartFlow FFR CT Analysis remains unparalleled in precision coronary care, as supported by the ACC/AHA Chest Pain Guidelines, to improve treatment plans and outcomes.

Coronary Artery Disease 59

Coronary Artery Disease Chest Pain Plaque Technology 59

DAIC

MARCH 5, 2024

Andrea Fletcher , Chief Digital Strategy Officer and Director of the Digital Service at Centers for Medicare and Medicaid Services ( CMS ) will present, “ Teaching the Elephant to Dance: Digital Transformation in the United States ” on March 13 in an afternoon education session.

CMS 52

CMS COVID-19 Medicare Education 52

Circulation

NOVEMBER 11, 2024

Using Current Procedural Technology codes, the first 150 patients that underwent carotid ultrasound in 2021 were identified.

Ultrasound 40

Ultrasound Medicare Technology Circulation 40

Stroke Journal

FEBRUARY 1, 2024

Introduction:This study evaluates the outcomes of a survivor-centric, navigator-driven, technology-enabled platform supporting survivors (SS) and care partners(CP) in post-stroke recovery.

Outcomes 40

Outcomes Strokes Stroke Quality of Life 40

GEMMS

MARCH 7, 2024

In late 2023, CMS released the 2024 Medicare Physician Fee Schedule (MPFS) Final Rule, ushering in key policy changes for the Quality Payment Program (QPP). Benchmarks for the 2023 performance period for eCQMs, MIPS CQMs, QCDR measures, and Medicare Part B claims are based on actual performance data submitted for the 2021 performance period.

Medicare 52

Medicare CMS Document Technology 52

Vector Remote

JUNE 30, 2023

1 For the care of patients with CIEDs on RM, manufacturers should include key stakeholders in the design and development of technologies for RM. 1 In patients with CIEDs on RM, the manufacturer should provide an RM system that is reliable, safe, accurate, and meets the needs of the patient.

Heart Rhythm 52

Heart Rhythm Education Patient Care Technology 52

Vector Remote

MARCH 9, 2023

Cardiac implantable devices are sophisticated technology that provide both therapy and diagnostics for patients with irregular heart rhythms. With effective management and use, RPM can provide clinicians with the tools to improve patient outcomes and deliver better quality care. What is Cardiac Remote Patient Monitoring Software ?

Heart Failure 52

Heart Failure Patient Care Heart Rhythm Hypertension 52

The Beat Blog

MAY 23, 2023

I learned about the complexities of health insurance – and after several years, I transitioned to the Medicare & Retirement Clinical value team where we worked to reduce the cost of United’s Medicare Advantage plans. Technology in healthcare is a double-edged sword.

Technology 52

Technology Gerontology Medicare Nursing 52

DAIC

MARCH 14, 2024

Ensure all Medicare Administrative Contractors (MACs) and health plans are accepting paper claims. Encourage the health information technology community to postpone user fees. Physicians need an up-to-date database that compiles all the payers that are offering advance payments to physicians.

CMS 101

CMS Medicare Medicaid Technology 101

Cardiometabolic Health Congress

JANUARY 19, 2024

Since 1923, technologies have emerged for insulin production, delivery of insulin, and blood glucose monitoring, including insulin pens, insulin pumps, lancets, test strips, and continuous glucose monitoring (CGM)—for those who can afford it. However, we continue to see incremental improvements in the field of insulin therapy.

Diabetes 59

Diabetes Medicare Diet CME 59

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The Society (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

DAIC

JANUARY 14, 2025

13, 2025 Medtronic plc recently announced that the Centers for Medicare & Medicaid Services (CMS) is opening a national coverage analysis (NCA) on renal denervation, a process that will allow the agency to review and develop a national Medicare coverage policy for renal denervation procedures for patients with hypertension.

CMS 52

CMS Medicare Blood Pressure Medicaid 52

DAIC

JANUARY 27, 2025

13, 2025 Medtronic recentlyannounced that the Centers for Medicare & Medicaid Services (CMS) is opening a national coverage analysis (NCA) on renal denervation, a process that will allow the agency to review and develop a national Medicare coverage policy for renal denervation procedures for patients with hypertension.

CMS 52

CMS Blood Pressure Medicare Hypertension 52

DAIC

JANUARY 13, 2025

Additionally, the company announced that the Centers for Medicare & Medicaid Services (CMS) has granted Category B approval for the investigational device exemption (IDE) study, ensuring Medicare coverage for the device, related and routine items, and services for the ELITE-BTK trial. Commenting on the announcements, Christopher M.

Peripheral Arterial Disease 52

Peripheral Arterial Disease CMS Medicare Medicaid 52